Pattern mixture models for longitudinal quality of life studies in advanced stage disease

Analyses of longitudinal quality of life (QOL) for patients with advanced stage disease are frequently plagued by problems of non-random drop-out attributable to deteriorating health and/or death. As an example, Moinpour et al. cite specific challenges which limited their report and assessment of QOL for patients treated for advanced stage colorectal cancer in a clinical trial of several chemotherapeutic regimes performed by the Southwest Oncology Group. A particular source of confusion that arises in studies of advanced stage disease is whether or not to differentiate loss of follow-up due to death from drop-out where the patient is still alive but has dropped from the study. In this paper we examine exploratory data techniques for longitudinal QOL data with non-random missingness due to drop-out and censorship by death. We propose a pattern mixture model for longitudinal QOL, time of drop-out and survival, which allows for straightforward implementation of sensitivity analyses and explicit comparisons to the raw data. Our method is illustrated in the context of analysing the data and addressing the challenges posed by Moinpour et al.

[1]  D. Osoba Lessons learned from measuring health-related quality of life in oncology. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Wulfsohn,et al.  Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS , 1995 .

[3]  Roderick J. A. Little,et al.  Modeling the Drop-Out Mechanism in Repeated-Measures Studies , 1995 .

[4]  J. Robins,et al.  Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models , 1999 .

[5]  S. Thompson,et al.  A joint analysis of quality of life and survival using a random effect selection model. , 2000, Statistics in medicine.

[6]  M. Wulfsohn,et al.  A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.

[7]  D. Thomas,et al.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. , 1996, Statistics in medicine.

[8]  M. Kenward,et al.  Informative Drop‐Out in Longitudinal Data Analysis , 1994 .

[9]  M. Schervish Theory of Statistics , 1995 .

[10]  Quality of Life in Advanced Prostate Cancer: Results of a Randomized Therapeutic Trial , 1998 .

[11]  N M Laird,et al.  Model-based approaches to analysing incomplete longitudinal and failure time data. , 1997, Statistics in medicine.

[12]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[13]  D. Osoba,et al.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Fleming,et al.  Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Roderick J. A. Little,et al.  A Class of Pattern-Mixture Models for Normal Incomplete Data , 1994 .

[16]  C. Moinpour,et al.  Challenges posed by non‐random missing quality of life data in an advanced‐stage colorectal cancer clinical trial , 2000, Psycho-oncology.

[17]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[18]  M D Schluchter,et al.  Methods for the analysis of informatively censored longitudinal data. , 1992, Statistics in medicine.

[19]  D. Osoba,et al.  Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. M. Taylor,et al.  Survival Analysis Using Auxiliary Variables Via Multiple Imputation, with Application to AIDS Clinical Trial Data , 2002, Biometrics.

[21]  D. Rubin Formalizing Subjective Notions about the Effect of Nonrespondents in Sample Surveys , 1977 .

[22]  D. Rubin INFERENCE AND MISSING DATA , 1975 .

[23]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[24]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[25]  D. Osoba,et al.  Health-related quality-of-life assessment in clinical trials of supportive care in oncology , 2000, Supportive Care in Cancer.

[26]  Yan Wang,et al.  Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome , 2001 .